Studies have demonstrated their capacity to mitigate various aspects of AD pathology, including the reduction in amyloid peptide levels, inhibition of tau phosphorylation, and attenuation of inflammatory responses [230,231]. The gene discussed is MAPT; the disease is Alzheimer disease.